3D exclaimation point leaning against a wall
FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
At its meeting on April 16-17, 2025, the Board considered recent updates regarding the stabilization of the national GLP-1 supply. The Board deferred to the FDA's memo on this topic. The Board's discussion during the meeting may be viewed in the Board's video meeting minutes - April 17, 2025 - Board Meeting Day 2 - 6:40:30.

Questions regarding the FDA's memo may be directed to the FDA at Compounding@fda.hhs.gov

Need to change your address/employment/PIC?

Need to verify a license, permit, or application?

Complaints / Suspicious Activity / Need To File A Complaint?